Trial intelligence / Profile preview

Hyalgan vs Shincort for Trigger Finger

NCT03131882Phase 3Unknown

Sponsor
Mahidol University
Start
Oct 2016
Primary completion
Jun 2017
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised trial of sodium hyaluronate in trigger finger (2 arms), sponsored by Mahidol University. Primary endpoint: Success rate at 6 months. Status: unknown.

02

Drugs

sodium hyaluronate
03

Conditions

trigger finger

Beyond the preview

Go deeper on NCT03131882.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03131882.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call